Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
(NYSE: ATH) Delayed: 83.33 --0 (-0%)
Previous Close $83.33    52 Week High $ 
Open $83.33    52 Week Low $ 
Day High $83.33    P/E N/A 
Day Low $83.33    EPS $ 
Volume 7,858       

(NASDAQ: ATHE) Delayed: 4.93 +0.05 (1.02%)
Previous Close $4.88    52 Week High $ 
Open $4.92    52 Week Low $ 
Day High $4.98    P/E N/A 
Day Low $4.90    EPS $ 
Volume 7,166